ArticleOpen access rheumatology : research and reviews2017

Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product.

Abuelmagd Abdalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.